Actively Recruiting
Treatment of Overweight and Obesity in Adolescents - Impact of a Sleep Behavioral Intervention - SLEEP-OB
Led by University of Beira Interior · Updated on 2025-12-01
126
Participants Needed
2
Research Sites
26 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are investigating how a sleep behavioral intervention combined with standard obesity treatment affects adolescents aged 13 to 17 who have overweight or obesity with poor sleep quality. The study aims to better understand how improving sleep may help reduce body fat and improve related health risks like insulin resistance and hypertension. This trial compares usual obesity treatment alone to usual treatment plus a sleep-focused behavioral therapy delivered by psychologists. Participants will be randomly assigned to either the control group receiving standard obesity care or the intervention group receiving standard care plus seven cognitive-behavioral therapy sessions over six months. These sessions focus on improving sleep hygiene, self-monitoring, stimulus control, cognitive therapy, and relaxation techniques. Medical visits occur every two months during the six-month intervention and every three months during a six-month follow-up period. During the study, participants will undergo assessments including body measurements BMI, waist circumference, fat mass, sleep evaluations using actigraphy and ambulatory sleep studies, blood tests for metabolic markers, and questionnaires on sleep, eating habits, physical activity, emotional well-being, and quality of life. The primary outcome is changes in BMI z-score and body composition at six months. Secondary outcomes include cardiometabolic risk factors, hormonal levels, and emotional measures, with safety and progress monitored throughout the 12-month study period.
CONDITIONS
Brief Title
Overweight and Obesity in Adolescents - Sleep Behavioral Intervention
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed informed consent from legal guardians and assent or consent from the adolescent
- Age between 13 and 17 years at consent
- Diagnosis of overweight (BMI z-score > 1 and 2) or obesity (BMI z-score > 2) by WHO criteria
- Poor sleep quality or sleep deprivation based on screening questionnaire
You will not qualify if you...
- Secondary obesity caused by hypothalamic, genetic, or endocrine conditions
- Comorbid psychiatric or neurological disorders affecting sleep, such as epilepsy or autism spectrum disorder
- Current treatment with selective serotonin reuptake inhibitors (SSRIs) or other medications that affect sleep
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here